Quality Verification with a Cluster−Controlled Manufacturing System to Generate Monocyte−Derived Dendritic Cells

Quality Verification with a Cluster−Controlled Manufacturing System to Generate Monocyte−Derived Dendritic Cells

Dendritic cell (DC) vaccines for cancer immunotherapy have been actively developed to improve clinical efficacy. In our previous report, monocyte−derived DCs induced by interleukin (IL)−4 with a low−adherence dish (low−adherent IL-4−DCs: la−IL-4−DCs) improved the yield and viability, as well as rela...

Full description

Bibliographic Details
Main Authors: Haruhiko Kawaguchi, Takuya Sakamoto, Terutsugu Koya, Misa Togi, Ippei Date, Asuka Watanabe, Kenichi Yoshida, Tomohisa Kato, Yuka Nakamura, Yasuhito Ishigaki, Shigetaka Shimodaira
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Vaccines
Subjects:
immunotherapy
dendritic cells
vaccine
cluster formation
cluster control
BCL2A1
Online Access:https://www.mdpi.com/2076-393X/9/5/533

Internet

https://www.mdpi.com/2076-393X/9/5/533

Similar Items